We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Innovative Approach Treats Recurrent Tracheaesophageal Fistulas

By HospiMedica International staff writers
Posted on 25 May 2021
A new study shows how an innovative surgical approach called posterior tracheopexy can help treat recurrent tracheaesophageal fistulas (TEFs).

Developed at Boston Children’s Hospital (BCH; MA, USA), the procedure involves dividing the TEF, repairing the esophagus and trachea, and suturing the posterior membranous section of the patient's trachea to the anterior longitudinal ligament of the spine. More...
The esophagus is also rotated into the right chest cavity, known as rotational esophagoplasty. As a result, both the esophageal and tracheal suture lines are separated, which eliminates the risk of re-recurrence by avoiding the need to interpose tissue or prosthetic mesh between the suture lines.

For the study, the researchers conducted a retrospective review of 62 patients with recurrent TEF, who were surgically treated with the posterior tracheopexy/rotational esophagoplasty at a median age of 14 months. All had significant respiratory symptoms, and 24 had earlier failed endoscopic and/or surgical attempts at repair. Results showed that postoperative morbidity included three esophageal leaks and one transient vocal cord dysfunction. No recurrences were identified at median follow-up of 2.5 years, and all symptoms were resolved. The study was published in the May 2021 issue of JACS.

“By performing a posterior tracheopexy after the division and repair of the recurrent TEF, we take advantage of the child's own tissue and nearby structural support provided by the spine to completely separate the suture lines,” said study co-lead author Benjamin Zendejas-Mummert, MD, of BCH. “In a field where re-recurrence of recurrent TEF has been common, the emergence of a procedure with a zero-percent recurrence rate and minimal morbidity is a game-changer.”

A TEF is a congenital defect in which an abnormal connection forms between a child's esophagus and trachea; it often occurs concomitant with esophageal atresia. Even after surgical repair, TEFs recur in about 10-15% of infants and children. They rarely close spontaneously, and typically require surgical or endoscopic intervention.

Related Links:
Boston Children’s Hospital


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.